Cargando…

Rebamipide as a Potential Alternative Gastroprotective Agent to Proton Pump Inhibitor in Elderly Chronic Nonsteroidal Anti-Inflammatory Drug Users without Risk Factors

PURPOSE: The use of proton pump inhibitors (PPI) is recommended to prevent nonsteroidal anti-inflammatory drug (NSAID)-induced gastrointestinal (GI) complications. The incidence of several adverse effects during the long-term use of PPI prompts the search for other alternatives. Limited studies have...

Descripción completa

Detalles Bibliográficos
Autores principales:	Lee, Mee Yeon, Lee, Suhyun, Heo, Kyu-Nam, Kim, Woo-Youn, Jung, Sun Hoi, Ah, Young-Mi, Lee, Ju-Yeun
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove 2022
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8922238/ https://www.ncbi.nlm.nih.gov/pubmed/35300126 http://dx.doi.org/10.2147/IJGM.S353098

Ejemplares similares

Nonsteroidal Anti-Inflammatory Drugs, Gastroprotection, and Benefit–Risk
por: Moore, Robert Andrew, et al.
Publicado: (2014)

Comparison of the Efficacy of Polaprezinc Plus Proton Pump Inhibitor and Rebamipide Plus Proton Pump Inhibitor Treatments for Endoscopic Submucosal Dissection-induced Ulcers
por: Jung, Da Hyun, et al.
Publicado: (2021)

Preventive Efficacy and Safety of Rebamipide in Nonsteroidal Anti-Inflammatory Drug-Induced Mucosal Toxicity
por: Kim, Jeong Ho, et al.
Publicado: (2014)

Cost Effectiveness of Gastroprotection with Proton Pump Inhibitors in Older Low-Dose Acetylsalicylic Acid Users in the Netherlands
por: Chau, Sek Hung, et al.
Publicado: (2017)

Patient-reported adherence to coprescribed proton pump inhibitor gastroprotection in osteoarthritis, rheumatoid arthritis, and ankylosing spondylitis patients using nonsteroidal anti-inflammatory drugs
por: Henriksson, Kenneth, et al.
Publicado: (2014)

Prescription behavior for gastroprotective drugs in new users as a result of communications regarding clopidogrel – proton pump inhibitor interaction
por: Kruik‐Kollöffel, Willemien J., et al.
Publicado: (2016)

Utilization of gastroprotective strategies for nonsteroidal anti-inflammatory drug-induced gastrointestinal events in a major teaching hospital
por: Lee, Hooi Leng, et al.
Publicado: (2016)

Gastroprotective Effects of Grape Seed Proanthocyanidin Extracts against Nonsteroid Anti-Inflammatory Drug-Induced Gastric Injury in Rats
por: Kim, Tae Ho, et al.
Publicado: (2013)

Gastroprotective Effect of Cochinchina momordica Seed Extract in Nonsteroidal Anti-Inflammatory Drug-Induced Acute Gastric Damage in a Rat Model
por: Lim, Ji Hwan, et al.
Publicado: (2014)

Proton pump inhibitors and gastroprotection in patients treated with antithrombotic drugs: A cardiologic point of view
por: Abrignani, Maurizio Giuseppe, et al.
Publicado: (2023)

Rebamipide ameliorates atherosclerosis by controlling lipid metabolism and inflammation
por: Jhun, JooYeon, et al.
Publicado: (2017)

Additive Effects of Rebamipide Plus Proton Pump Inhibitors on the Expression of Tight Junction Proteins in a Rat Model of Gastro-Esophageal Reflux Disease
por: Gweon, Tae-Geun, et al.
Publicado: (2018)

Coprescribing proton-pump inhibitors with nonsteroidal anti-inflammatory drugs: risks versus benefits
por: Gwee, Kok Ann, et al.
Publicado: (2018)

Rebamipide Plus Proton Pump Inhibitor Versus Proton Pump Inhibitor Alone in the Treatment of Endoscopic Submucosal Dissection-Induced Gastric Ulcer: Retracted: A Meta-Analysis of Randomized Controlled Trials
por: Xiong, Ji, et al.
Publicado: (2014)

Limited Effect of Rebamipide in Addition to Proton Pump Inhibitor (PPI) in the Treatment of Post-Endoscopic Submucosal Dissection Gastric Ulcers: A Randomized Controlled Trial Comparing PPI Plus Rebamipide Combination Therapy with PPI Monotherapy
por: Nakamura, Kazuhiko, et al.
Publicado: (2016)

Rebamipide with Proton Pump Inhibitors (PPIs) versus PPIs Alone for the Treatment of Endoscopic Submucosal Dissection-Induced Ulcers: A Meta-analysis
por: Liu, Junyuan, et al.
Publicado: (2020)

Rebamipide ameliorates indomethacin-induced small intestinal damage and proton pump inhibitor-induced exacerbation of this damage by modulation of small intestinal microbiota
por: Tanigawa, Tetsuya, et al.
Publicado: (2021)

Notice of Retraction: Rebamipide plus proton pump inhibitor versus proton pump inhibitor alone in treatment of endoscopic submucosal dissection-induced gastric ulcer: a meta-analysis of randomized controlled trials
Publicado: (2014)

The Garlic Preparation as an Alternative Way for Gastroprotection: From Bench to Clinic
por: Park, Jong-Jae
Publicado: (2016)

Combination of proton pump inhibitor and rebamipide, a free radical scavenger, promotes artificial ulcer healing after endoscopic submucosal dissection with dissection size >40 mm
por: Araki, Hiroshi, et al.
Publicado: (2012)

Long‐term use of proton pump inhibitors and prevalence of disease‐ and drug‐related reasons for gastroprotection—a cross‐sectional population‐based study
por: Wallerstedt, Susanna M., et al.
Publicado: (2016)

Nonsteroidal anti‐inflammatory drugs prevent gastric cancer associated with the use of proton pump inhibitors after Helicobacter pylori eradication
por: Arai, Junya, et al.
Publicado: (2021)

Comparative evaluation of antibacterial efficacy of nonsteroidal anti-inflammatory medications and proton-pump inhibitor against Enterococcus faecalis: An in vitro study
por: Tilokani, Akansha, et al.
Publicado: (2023)

Development and validation of a risk-score model for opioid overdose using a national claims database
por: Heo, Kyu-Nam, et al.
Publicado: (2022)

Non-steroidal anti-inflammatory drugs and gastroprotection in primary health care users
por: Shabani, Driton, et al.
Publicado: (2020)

Risk of Pyogenic Liver Abscess in Proton Pump Inhibitor Users: New Inventory of Proton Pump Inhibitor Induced Complications?
por: Bang, Ki Bae
Publicado: (2021)

A Case-Control Study of Esomeprazole Plus Rebamipide vs. Omeprazole Plus Rebamipide on Post-ESD Gastric Ulcers
por: Bunno, Maki, et al.
Publicado: (2013)

Evaluation of symptomatic reflux esophagitis in proton pump inhibitor users
por: Asaoka, Daisuke, et al.
Publicado: (2019)

Rebamipide and mosapride enhance pilocarpine-induced salivation
por: Urita, Yoshihisa, et al.
Publicado: (2009)

Anti-inflammatory effect of rebamipide on the ocular surface
por: Ueta, Mayumi, et al.
Publicado: (2013)

Topical rebamipide improves lid wiper epitheliopathy
por: Itakura, Hirotaka, et al.
Publicado: (2013)

Efficacy of Exemestane in Korean Patients with Metastatic Breast Cancer after Failure of Nonsteroidal Aromatase Inhibitors
por: Lee, June Koo, et al.
Publicado: (2013)

Is the Diagnostic Trial with Proton Pump Inhibitors Reasonable for School Age Children with Gastroesophageal Reflux Symptoms?
por: Yang, Jaeeun, et al.
Publicado: (2019)

Flavonoids with Gastroprotective Activity
por: de Lira Mota, Kelly Samara, et al.
Publicado: (2009)

Proton Pump Inhibitors Increase the Risk of Nonsteroidal Anti-inflammatory Drug-Related Small-Bowel Injury: A Systematic Review With Meta-analysis
por: Zhang, Xian, et al.
Publicado: (2023)

Gastroprotective Effect of the Three Glucuronopyranoside Flavonoids in Rats
por: Im, Wi Joon, et al.
Publicado: (2013)

Rebamipide treatment ameliorates obesity phenotype by regulation of immune cells and adipocytes
por: Jhun, JooYeon, et al.
Publicado: (2022)

Gastroprotective Effects of PMK-S005 against Ethanol-Induced Acute Gastric Damage in Rats
por: Choi, Yoon Jeong, et al.
Publicado: (2016)

Topical rebamipide improves the ocular surface in mild lagophthalmos
por: Itakura, Mariko, et al.
Publicado: (2013)

Efficacy and safety of 1% and 2% rebamipide clear solution in dry eye disease: a multicenter randomized trial
por: Eom, Youngsub, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_q14g4c786sou81ihl76lq3uhsu